Recruiting · registry status

Homeopathy added to usual Parkinson's care

Researchers are studying homeopathic preparations alongside standard care. The listing does not establish that this approach is effective.

Testing a treatment or activity · Study reference: CTRI-2026-03-105121

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported date): 2026-03-15

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded

2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Age range not listed · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: Not reported

Inclusion criteria: 1.Patients aged 50-80 years 2.Both genders 3.The diagnosis of PD as established using the UK Parkinsons Disease Society Brain Bank Clinical diagnostic criteria or Any of the four common types of Parkinson plus Syndrome diagnosed by a neurologist as per the following Criteria Multiple System atrophy- Movement disorder society criteria Progressive Supranuclear Palsy (PSP)- NINDS and Society for PSP criteria Cortical Basal Degeneration (CBD)- New consensus criteria of Armstrong for diagnosis of CBD Dementia with Lewy bodies- Revised Consensus criteria for diagnosis of DLB 2017 4.Parkinsons Disease severity of 1 to 3 according to the modified Hoehn & Yahr scale 5.Participants with other comorbidities such as controlled diabetes, controlled hypertension 6.Participants with other comorbidities that seem fit as per the treating physician 7.Participants are willing to give written informed consent. Exclusion criteria: Patients who meet any of the following criteria will be excluded from participating in the study: Patients suffering from any mental health problems: schizophrenia, bipolar affective disorder, or other psychotic illnesses. Life-threatening illnesses, malignant tumors, HIV. Parkinson s disease with severity 4 as per the modified Hoehn & Yahr scale. Concurrent severe and/or uncontrolled and/or unstable other medical disease that, in the opinion of the Investigator, may significantly interfere with study compliance. Inability to comply with the study protocol.

Full study name & original research details

Official study title

Evaluating the impact of add-on Homoeopathy in patients with Parkinson s disease and Parkinson plus syndrome: A Single blind randomized controlled feasibility trial

Short title used by the registry

Role of homoeopathy in Parkinson s Disease

Original description

Intervention: Intervention1: Individualized Homoeopathic medicine (IH) + Standard care (SC): Participants will be given individualized homoeopathic medicine in LM potency dispensed with liquid preparation and administered orally on a clean tongue as per homoeopathic principles, along with standard care. Control Intervention1: Placebo + Standard care: All participants in this group will receive placebo and standard care as in the Intervention group. Primary outcome: To assess if homeopathy has added benefits in the treatment of patients with Parkinson s disease and Parkinson-plus syndrome during 12 months of treatment as assessed using the MDS-UPDRS questionnaire in the two groups. To evaluate the progression of supranuclear palsy using the PSPRS for Parkinson plus syndrome during 12 months of treatment in the two groups. Timepoint: Baseline, month 6, & month 12 in the two groups Secondary outcome: Evaluation of the effect of homeopathy on health-related quality of life (HRQoL) using PDQ-39Timepoint: Baseline, month 6, & month 12 in the two groups;Assessment of the Functional status by the Mini-Mental State Examination (MMSE), in Parkinson disease with mild cognitive impairment: MMSE score,Parkinson disease with dementia: MMSE score,Parkinson disease with normal cognition: MMSE scoreTimepoint: Baseline, month 6, & month 12 in the two groups;Assessment of the Serum Biomarker by alpha-synuclein at Baseline, month 6, & month 12 in the two groups.Timepoint: Baseline, month 6, & month 12 in the two groups;Assessment of the brain activity abnormalities in Parkinson s disease (PD) by EEGTimepoint: Baseline, month 6, & month 12 in the two groups;Changes in blood parameters like CBC, LFT, KFT, sugar profile (HbA1C), or as suggested by the investigator depending upon the Co-morbidity suffered by the patientTimepoint: Baseline, month 3, 6, 9 & month 12 in the two groups;Reduction of standard care medication in the two groups Timepoint: Baseline, month 6, & month 12 in the two groups

Conditions reported: Health Condition 1: G20- Parkinsons disease

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

CTRI · CTRI/2026/03/105121 ↗ — Recruiting; WHO ICTRP processed 2026-03-30; checked 2026-10-14

Study type: Interventional
Interventions: Intervention1: Individualized Homoeopathic medicine (IH) + Standard care (SC): Participants will be given individualized homoeopathic medicine in LM potency dispensed with liquid preparation and administered orally on a clean tongue as per homoeopathic principles, along with standard care. Control Intervention1: Placebo + Standard care: All participants in this group will receive placebo and standard care as in the Intervention group.
Phases: Phase 3
Sponsor: Central Council for Research in Homoeopathy
Start date reported by registry: 2026-03-15 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-14 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Dr Varanasi Roja · 07094630047 · prasad77.md@gmail.com

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

India

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.